Mizuho Medy Co.,Ltd. (4595.T)
JPY 1452.0
(-0.07%)
JPY 1452.0
(-0.07%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.98 Billion JPY | -37.49% |
| 2022 | 17.58 Billion JPY | 36.44% |
| 2021 | 12.88 Billion JPY | 206.57% |
| 2020 | 4.2 Billion JPY | -34.6% |
| 2019 | 6.42 Billion JPY | 0.03% |
| 2018 | 6.42 Billion JPY | 14.24% |
| 2017 | 5.62 Billion JPY | 13.34% |
| 2016 | 4.96 Billion JPY | 21.53% |
| 2015 | 4.08 Billion JPY | 2.14% |
| 2014 | 3.99 Billion JPY | 23.07% |
| 2013 | 3.24 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.92 Billion JPY | -29.76% |
| 2024 Q1 | 2.74 Billion JPY | -8.58% |
| 2023 Q4 | 2.99 Billion JPY | -12.17% |
| 2023 Q2 | 2.18 Billion JPY | -8.69% |
| 2023 Q3 | 3.41 Billion JPY | 56.36% |
| 2023 FY | 10.98 Billion JPY | -37.49% |
| 2023 Q1 | 2.39 Billion JPY | -44.38% |
| 2022 Q2 | 3.12 Billion JPY | -25.38% |
| 2022 Q3 | 5.96 Billion JPY | 90.94% |
| 2022 Q4 | 4.3 Billion JPY | -27.94% |
| 2022 FY | 17.58 Billion JPY | 36.44% |
| 2022 Q1 | 4.18 Billion JPY | 64.2% |
| 2021 Q4 | 2.55 Billion JPY | -37.14% |
| 2021 Q3 | 4.05 Billion JPY | 3.94% |
| 2021 Q2 | 3.9 Billion JPY | 64.43% |
| 2021 FY | 12.88 Billion JPY | 206.57% |
| 2021 Q1 | 2.37 Billion JPY | 38.78% |
| 2020 Q4 | 1.71 Billion JPY | 106.4% |
| 2020 Q3 | 828.87 Million JPY | 35.64% |
| 2020 Q2 | 611.08 Million JPY | -41.95% |
| 2020 Q1 | 1.05 Billion JPY | -54.23% |
| 2020 FY | 4.2 Billion JPY | -34.6% |
| 2019 Q2 | 1.03 Billion JPY | -43.22% |
| 2019 FY | 6.42 Billion JPY | 0.03% |
| 2019 Q4 | 2.29 Billion JPY | 79.6% |
| 2019 Q3 | 1.28 Billion JPY | 24.19% |
| 2019 Q1 | 1.81 Billion JPY | -15.65% |
| 2018 FY | 6.42 Billion JPY | 14.24% |
| 2018 Q3 | 1.17 Billion JPY | 24.78% |
| 2018 Q1 | 2.15 Billion JPY | 4.56% |
| 2018 Q2 | 943.18 Million JPY | -56.18% |
| 2018 Q4 | 2.15 Billion JPY | 82.91% |
| 2017 Q3 | 1.03 Billion JPY | 15.44% |
| 2017 FY | 5.62 Billion JPY | 13.34% |
| 2017 Q1 | 1.63 Billion JPY | -19.22% |
| 2017 Q4 | 2.05 Billion JPY | 98.61% |
| 2017 Q2 | 897.82 Million JPY | -44.96% |
| 2016 Q3 | 789.11 Million JPY | 14.52% |
| 2016 Q4 | 2.01 Billion JPY | 155.91% |
| 2016 Q1 | 1.46 Billion JPY | -0.24% |
| 2016 FY | 4.96 Billion JPY | 21.53% |
| 2016 Q2 | 689.08 Million JPY | -52.95% |
| 2015 FY | 4.08 Billion JPY | 2.14% |
| 2015 Q4 | 1.46 Billion JPY | 0.0% |
| 2014 FY | 3.99 Billion JPY | 23.07% |
| 2013 FY | 3.24 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | 82.317% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 99.742% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 96.506% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 97.474% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -42.015% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 92.587% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | 84.746% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 98.518% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | 11.416% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 92.245% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 89.318% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | 80.165% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | 64.259% |
| Tsumura & Co. | 150.84 Billion JPY | 92.715% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | 85.459% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | 79.886% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 95.179% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | 73.123% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 85.487% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 90.806% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -118.05% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | 76.565% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -96.607% |
| MedRx Co., Ltd | 26 Million JPY | -42168.212% |
| Solasia Pharma K.K. | 617 Million JPY | -1681.156% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | 82.512% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 93.786% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -17882.941% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 99.256% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | 50.349% |